AR033979A1 - Metodo para preparar un polipeptido il-18 fisiologicamente activo - Google Patents

Metodo para preparar un polipeptido il-18 fisiologicamente activo

Info

Publication number
AR033979A1
AR033979A1 ARP010102818A ARP010102818A AR033979A1 AR 033979 A1 AR033979 A1 AR 033979A1 AR P010102818 A ARP010102818 A AR P010102818A AR P010102818 A ARP010102818 A AR P010102818A AR 033979 A1 AR033979 A1 AR 033979A1
Authority
AR
Argentina
Prior art keywords
polypeptide
active polypeptide
physiologically active
preparing
precursor
Prior art date
Application number
ARP010102818A
Other languages
English (en)
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of AR033979A1 publication Critical patent/AR033979A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/54Interleukins [IL]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Un método para producir un polipéptido fisiológicamente activo, que comprende poner en contacto un polipéptido precursor con una enzima activante, o co-expresar el polipéptido con una proteasa activante. Un método para producir un polipéptido activo a partir de un polipéptido precursor de ese polipéptido, que tiene un segmento de activación de proteasa que comprende la secuencia de aminoácidos XEYD, donde X se selecciona de un grupo de aminoácidos formado por W, L, F, Y, I, V, D ó E; e Y se selecciona de un grupo de aminoácidos formado por H, I, A, T, S, P ó E, que comprende: (i) poner en contacto caspasa 4 con el polipéptido precursor y (ii) purificar el polipéptido activo.
ARP010102818A 2000-06-15 2001-06-13 Metodo para preparar un polipeptido il-18 fisiologicamente activo AR033979A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US21183200P 2000-06-15 2000-06-15
US22412800P 2000-08-10 2000-08-10
US26492301P 2001-01-20 2001-01-20

Publications (1)

Publication Number Publication Date
AR033979A1 true AR033979A1 (es) 2004-01-21

Family

ID=27395664

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010102818A AR033979A1 (es) 2000-06-15 2001-06-13 Metodo para preparar un polipeptido il-18 fisiologicamente activo

Country Status (25)

Country Link
US (2) US7186528B2 (es)
EP (1) EP1292697B1 (es)
JP (1) JP5121109B2 (es)
KR (1) KR20030022144A (es)
CN (1) CN100390281C (es)
AR (1) AR033979A1 (es)
AT (1) ATE437234T1 (es)
AU (2) AU2001280442B2 (es)
BR (1) BR0111692A (es)
CA (1) CA2412730C (es)
CZ (1) CZ20024085A3 (es)
DE (1) DE60139316D1 (es)
DK (1) DK1292697T3 (es)
ES (1) ES2329875T3 (es)
HK (1) HK1055138A1 (es)
HU (1) HUP0501002A3 (es)
IL (2) IL153422A0 (es)
MX (1) MXPA02012292A (es)
MY (1) MY136526A (es)
NO (1) NO330682B1 (es)
NZ (1) NZ522845A (es)
PL (2) PL366134A1 (es)
PT (1) PT1292697E (es)
SI (1) SI1292697T1 (es)
WO (1) WO2001098455A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2338515A3 (en) * 2000-02-10 2011-11-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
ATE459647T1 (de) 2003-04-15 2010-03-15 Glaxosmithkline Llc Humane il-18 substitutionsmutanten und deren konjugate
AU2004266213A1 (en) * 2003-08-15 2005-03-03 University Of Florida Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases
US7968684B2 (en) * 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
JP2007512008A (ja) * 2003-11-24 2007-05-17 ノボ ノルディスク アクティーゼルスカブ 融合タンパク質及び該タンパク質の切断方法
PL1793859T3 (pl) * 2004-08-20 2009-08-31 Smithkline Beecham Corp Leczenie zapalenia śluzówki jamy ustnej i jelit przez podawanie ludzkiej IL-18
WO2008033499A2 (en) 2006-09-14 2008-03-20 The Trustees Of The University Of Pennsylvania Modulation of regulatory t cells by human il-18
PE20090190A1 (es) * 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
KR101940430B1 (ko) 2014-08-07 2019-01-18 가꼬우호우징 효고 이카다이가쿠 Il-18과 분자 표적 항체를 병용하는 암 치료약
JP2019023165A (ja) * 2015-12-11 2019-02-14 国立大学法人京都大学 インターロイキン−18活性阻害剤
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985863A (en) * 1996-09-12 1999-11-16 Vertex Pharmaceuticals, Inc. Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5192324A (en) 1982-02-18 1993-03-09 Howmedica Inc. Bone prosthesis with porous coating
ATE247708T1 (de) * 1986-10-02 2003-09-15 Massachusetts Inst Technology Verfahren zur regulierung der metabolischen stabilität von proteinen
US5212058A (en) 1990-05-09 1993-05-18 Massachusetts Institute Of Technology Nucleic acid encoding ubiquitin-specific proteases
DK0531404T3 (da) 1990-05-09 1995-09-18 Massachusetts Inst Technology Ubiquitin-specifik protease
US5914254A (en) 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US6110701A (en) 1994-04-08 2000-08-29 Merck Frosst Canada & Co. DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
US5552536A (en) 1994-04-08 1996-09-03 Merck Frosst Canada, Inc. DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
EP0692536B1 (en) 1994-07-14 2000-11-22 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo IFN-Y production inducing protein and monoclonal antibody of the same
JP2724987B2 (ja) 1994-11-15 1998-03-09 株式会社林原生物化学研究所 インターフェロン−γの産生を誘導するポリペプチド
TW464656B (en) 1994-11-15 2001-11-21 Hayashibara Biochem Lab Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
US6074050A (en) 1997-12-03 2000-06-13 Hewlett-Packard Company Method and apparatus for venting an ink container
AU1341797A (en) 1995-12-29 1997-07-28 Incyte Pharmaceuticals, Inc. Nucleic acids encoding interferon gamma inducing factor-2
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
JP4010606B2 (ja) * 1996-07-25 2007-11-21 株式会社林原生物化学研究所 ポリペプチドの製造方法
US6054487A (en) 1997-03-18 2000-04-25 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
KR20010034305A (ko) * 1998-01-23 2001-04-25 한센 핀 베네드 효모에서 원하는 폴리펩티드를 만드는 방법

Also Published As

Publication number Publication date
US7442526B2 (en) 2008-10-28
EP1292697A4 (en) 2005-08-10
PT1292697E (pt) 2009-10-28
BR0111692A (pt) 2005-08-30
WO2001098455A2 (en) 2001-12-27
HK1055138A1 (en) 2003-12-24
AU8044201A (en) 2002-01-02
HUP0501002A3 (en) 2010-01-28
WO2001098455A3 (en) 2002-08-08
ATE437234T1 (de) 2009-08-15
US7186528B2 (en) 2007-03-06
US20030143198A1 (en) 2003-07-31
US20060177422A1 (en) 2006-08-10
HUP0501002A2 (en) 2006-01-30
IL153422A (en) 2011-03-31
EP1292697A2 (en) 2003-03-19
PL208592B1 (pl) 2011-05-31
EP1292697B1 (en) 2009-07-22
KR20030022144A (ko) 2003-03-15
DE60139316D1 (de) 2009-09-03
IL153422A0 (en) 2003-07-06
NZ522845A (en) 2005-07-29
NO20026002D0 (no) 2002-12-13
CZ20024085A3 (cs) 2003-05-14
NO330682B1 (no) 2011-06-06
PL366134A1 (en) 2005-01-24
JP2004523204A (ja) 2004-08-05
SI1292697T1 (sl) 2009-12-31
MY136526A (en) 2008-10-31
AU2001280442B2 (en) 2005-10-27
MXPA02012292A (es) 2003-04-25
CN1436246A (zh) 2003-08-13
DK1292697T3 (da) 2009-11-16
CN100390281C (zh) 2008-05-28
ES2329875T3 (es) 2009-12-02
NO20026002L (no) 2003-02-12
CA2412730C (en) 2011-08-16
CA2412730A1 (en) 2001-12-27
JP5121109B2 (ja) 2013-01-16

Similar Documents

Publication Publication Date Title
AR033979A1 (es) Metodo para preparar un polipeptido il-18 fisiologicamente activo
EP1180371A4 (en) AGENTS PROMOTING THE FORMATION OF A BASIC SKIN MEMBRANE, AGENTS PROMOTING THE FORMATION OF ARTIFICIAL SKIN AND METHOD FOR PRODUCING ARTIFICIAL SKIN
AR023529A1 (es) Una composicion champu acondicionadora del cabello y un metodo para acondicionar el cabello
HUP0300299A2 (hu) Szabad aminosavakat tartalmazó kompozíció
ATE496123T1 (de) Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden
PT695169E (pt) Lipossomas multivesiculares de ciclodextrina encapsulando compostos farmacologicos e metodos para a sua utilizacao
TW200505471A (en) Casein hydrolysate, method of preparing the same, and use of the same
ATE456648T1 (de) Verfahren zur herstellung von l-aminosäure
ATE455876T1 (de) Verfahren zur laserabscheidung
DE60110106D1 (de) Verfahren zur herstellung von pankreasenzym enthaltende mikrosphären mit hoher stabilität
HUP0303246A2 (hu) Aktív fehérjék fokozott kinyerése
ATE334136T1 (de) Verfahren zur herstellung von azithromycin
DK1141205T3 (da) Subtilase-enzymer fra I-S1 og I-S2 sub-grupperne, som har en yderligere aminosyrerest i en aktiv site loop region
GB0100551D0 (en) Protein
AR039857A1 (es) Preparaciones de una sulfinilacetamida
ES2160410T3 (es) Preparados de complejos de protrombina inmunotolerantes.
DK1329462T3 (da) Fremgangsmåde til fremstilling af human serumalbumin, som inddrager opvarmningstrin
YU62000A (sh) Postupak za proizvodnju nezasićenih 4,5-alenketona, 3,5-dienketona i odgovarajućih zasićenih ketona
EP1384778A4 (en) PROTEIN SYNTHESIS METHOD USING ACELLULAR PROTEIN SYNTHESIS SYSTEM
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa
WO1998012225A3 (de) Verfarhen zur herstellung eines plasmaprotein-hältigen arzneimittels
ATE335745T1 (de) Verfahren zur herstellung von protease hemmenden zwischenprodukten
FI950094A0 (fi) Menetelmä vesipohjaisen entsyymiliuoksen puhdistamiseksi
ATE300311T1 (de) Vorbereitung eines medikaments zur behandlung von refluxösophagitis
BRPI9913018A (pt) processo para a preparação de somatotropina ativa a partir de corpúsculos de inclusão.

Legal Events

Date Code Title Description
FG Grant, registration